What's New in Migraine? AHS Updates

In part two of this series, Drs. Shuvro Roy, Jiwon Oh, and Amit Bar-Or discuss the results of the FENhance 1 and 2 trials looking at fenebrutinib in relapsing MS. For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting. Read more abo ...  Show more

In part one of this series, Drs. Shuvro Roy, Jiwon Oh, and Amit Bar-Or discuss the results of the fenebrutinib trial and highlight the key takeaways that healthcare providers should be aware of. For more information, please read about the abstract that was presented at the 2026 A ...  Show more

Dr. Tesha Monteith talks with Dr. Messoud Ashina about the comparison between cortical morphometry to a large sample of people with migraine and healthy controls, as well as across migraine subtypes. Read the related article in Neurology. This podcast is sponsored by argenx. Visi ...  Show more

Dr. Tesha Monteith talks with Dr. Peter Goadsby about updates on migraine treatments and the integration of CGRP inhibitors into clinical practice. Disclosures can be found at Neurology.org 

Dr. Tesha Monteith talks with Dr. Mark Burish about circadian-targeted research into cluster headaches and migraines.

Read the related article in Neurology. 

Disclosure ...

1 in 7 people live with migraines around the world, and the condition costs the UK economy billions each year. Attacks can be debilitating and all-consuming, but a new treatment recently approved by NICE might even help the most stubborn cases find some relief. James Gallagher is ...  Show more